Recently, it has been reported that ABCB1 corresponds to trigger the development of chemo drug resistance [102], thus, it seems that ABCB1 down-regulation could be an effective strategy in sensitizing cancer cells to different chemotherapies. Here, ABCB1 is linked to cancer.